관련문헌 등(*필요시 생략 가능)
·Guglielmo Mariani, et al. Hematology: Basic Principles and Practice. 7th Edition. Elsevier Inc. 2018.
·Valder R. Arruda, et al. Harrison's Principles of Internal Medicine, 20th Edition. McGraw-Hill Education. 2018.
·Kenneth Kaushansky, et al. Williams Hematology. 9th Edition. McGraw-Hill Education. 2016.
·Suchitra S. Acharya, et al. Lanzkowsky's Manual of Pediatric Hematology and Oncology. 6th Edition. Elsevier Inc. 2016.
·J. Paul Scott, et al. Nelson Textbook of Pediatrics. Twentieth Edition. Elsevier Inc. 2016.
·Rolf Ljung, et al. Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication, and strategies for difficult-to-treat patients. European Journal of Haematology. 2018
·Gerry Dolan, et al. Haemophilia B: Where are we now and what does the future hold? Blood Reviews. 2018;32:52？60.
·Alok Srivastava, et al. Guidelines for the management of hemophilia. 2nd Edition. WFH. 2012.
·Gary Benson, et al. Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice. European Journal of Haematology. 2012;88:371？379.
·A guide to the management of patients with inhibitors to factor Ⅷ and factor Ⅸ. AHCDC. 2010.
·Guidelines for the treatment of inhibitors in haemophilia A and haemophilia B. AHCDO. 2010.
·D. M. DIMICHELE, et al. International workshop on immune tolerance induction: consensus recommendations. Haemophilia. 2007;13(1):1？22.
·Andrea Bon, et al. Desensitization and immune tolerance induction in children with severe factor IX deficiency; inhibitors and adverse reactions to replacement therapy: a case-report and literature review. Italian Journal of Pediatrics. 2015;41:12.
·Katharina Holstein, et al. Successful second ITI with factor IX and combined immunosuppressive therapy. A patient with severe haemophilia B and recurrence of a factor IX inhibitor. Hamostaseologie. 2014;34(1):S5-8.
·Angelika Batorova, et al. Challenges in the Management of Hemophilia B with Inhibitor. Semin Thromb Hemost. 2013;39:767？771.
·Castaman G, et al. Inhibitors in haemophilia B: the Italian experience.. Haemophilia. 2013;19(5):686-90.
·S. RANTA, et al. Identical but different: haemophilia B in monozygotic twins with inhibitor in one brother and subsequent successful immune tolerance induction. Haemophilia. 2012;18: e347-e363.
·K. NAGEL, et al. Immune tolerance induction for a patient with factor IX inhibitors ？ a case report. Haemophilia.2011;17(15):312？326.
·C. BARNES, et al. Induction of immune tolerance using rituximab in a child with severe haemophilia B with inhibitors and anaphylaxis to factor IX. Haemophilia. 2010;6:840？842.
·M. CHITLUR, et al. Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006). Haemophilia. 2009;15:1027~31.
·D. DIMICHELE. The North American Immune Tolerance Registry: contributions to the thirty-year experience with immune tolerance therapy. Haemophilia. 2009;15:320？328.
·Karin Beutel, et al. ITI with high-dose FIX and combined immunosuppressive therapy in a patient with severe haemophilia B and inhibitor. Hamostaseologie. 2009;29:155-7.
·D. KLARMANN, et al. Immune tolerance induction with mycophenolate-mofetil in two children with haemophilia B and inhibitor. Haemophilia. 2008;14:44？49.